Skip to content

Speakers

Expand/Collapse

Boris Gorovits
Senior Director
Pfizer

Gregory LaRosa
Senior Vice President & Head of Scientific Research, Rare Disease Research Unit
Pfizer

Joyce Lo
Scientist
Biogen

Mark Milton
Global Head, Pharmacokinetic Sciences Ophthalmology Therapeutic Area & Department Lead for Gene Therapies
Novartis

Martin Childers
Chief Medical Officer
AskBio

Natasha Penner
Director, Clinical Pharmacology & Pharmacometrics
Biogen

Robert Bell
Associate Research Fellow
Pfizer

Timothy MacLachlan
Executive Director, Global Head of Biologics Safety Assessment
Novartis

Lamya Shihabuddin
Head of Genetic Neurologic Diseases
Sanofi

Martin Citron
Vice President, Neuroscience Research
UCB

Gabriele Proetzel
Director, Neuroscience External Research
Takeda

Sander Van Deventer
Executive Vice President, Research & Product Development
uniQure

David Schaffer
Professor of Chemical & Biomolecular Engineering | Co-Founder & Acting Chief Scientific Officer
UC Berkeley | 4D Molecular Therapeutics

Gavin Corcoran
Chief Research & Development Officer
Axovant

Omar Khwaja
Chief Medical Officer
Voyager Therapeutics

David Theron
Prospective & Opportunities Director, CNS
Servier

Klaudia Kuranda
Immunology Leader
Spark Therapeutics

Petra Kaufmann
Vice President, R&D Translational Medicine
AveXis

Jodi Cook
Head of Gene Therapy Strategy
PTC Therapeutics

Carol Satler, M.D., Ph.D.
Vice President, Regional Medical Officer
PPD Biotech

Eloise Hudry

Novartis

Emily Hickey
Chief Operations Officer
Biomere

Ira Goodman
Principal Investigator
Compass Clinic

Mark Nedelman
Chief Executive Officer
Biomere

Timothy Miller
Vice President & Area Head, Pediatrics & Rare Diseases
PPD Biotech

Jonathan Brotchie
Co-Founder, Director & President
Atuka Inc